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Abstract
Background: Currently less than 15% of children under five with fever receive recommended artemisinin-
combination therapy (ACT), far short of the Roll Back Malaria target of 80%. To understand why coverage remains
low, it is necessary to examine the treatment pathway from a child getting fever to receiving appropriate
treatment and to identify critical blockages. This paper presents the application of such a diagnostic approach to
the coverage of prompt and effective treatment of children with fever in rural Senegal.
Methods: A two-stage cluster sample household survey was conducted in August 2008 in Tambacounda, Senegal,
to investigate treatment behaviour for children under five with fever in the previous two weeks. The treatment
pathway was divided in to five key steps; the proportion of all febrile children reaching each step was calculated.
Results were stratified by sector of provider (public, community, and retail). Logistic regression was used to
determine predictors of treatment seeking.
Results: Overall 61.6% (188) of caretakers sought any advice or treatment and 40.3% (123) sought any treatment
promptly within 48 hours. Over 70% of children taken to any provider with fever did not receive an anti-malarial.
The proportion of febrile children receiving ACT within 48 hours was 6.2% (19) from any source; inclusion of
correct dose and duration reduced this to 1.3%. The proportion of febrile children receiving ACT within 48 hours
(not including dose & duration) was 3.0% (9) from a public provider, 3.0% (9) from a community source and 0.3%
(1) from the retail sector. Inclusion of confirmed diagnosis within the public sector treatment pathway as per
national policy increases the proportion of children receiving appropriate treatment with ACT in this sector from
9.4% (9/96) to an estimated 20.0% (9/45).
Conclusions: Process analysis of the treatment pathway for febrile children must be stratified by sector of
treatment-seeking. In Tambacounda, Senegal, interventions are needed to increase prompt care-seeking for fever,
improve uptake of rapid diagnostic tests at the public and community levels and increase correct treatment of
parasite-positive patients with ACT. Limited impact will be achieved if interventions to improve prompt and
effective treatment target only one step in the treatment pathway in any sector.
Background
Prompt and effective case management is a key compo-
nent of global strategies to reduce the burden of
malaria. The Roll Back Malaria Partnership (RBM) has
set the target for 2010 that “80% of malaria patients are
diagnosed and treated with effective anti-malarial medi-
cines, e.g. artemisinin-based combination therapies
(ACT), within one day of the onset of illness” [1]. Avail-
able data on progress towards this goal suggest that the
mean proportion of children under five years of age
with a fever that were treated with an anti-malarial drug
in sub-Saharan Africa between 2007 and 2008 was 32%
(varying across countries from 6% to 57%); less than
15% of children were given an ACT (range: 3% to 25%)
[2]. These data do not include a measure of the prompt-
ness of treatment. Therefore, considering the delays in
treatment-seeking reported elsewhere [3], it is likely
that the proportion of children receiving an appropriate
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anti-malarial drug within one day of the onset of illness
will be even lower.
Alongside the shift in national treatment polices to the
use of more expensive forms of ACT, the policy process
has recently changed to include parasitological diagnosis
rather than presumptively treating all fevers as malaria
[4]. This is particularly the case in the public sector
[5,6], however increasingly discussions are also moving
towards introducing use of rapid diagnostic tests (RDTs)
by community health workers [7,8]. Thus, it is impor-
tant to consider diagnosis-confirmed cases of malaria,
not just any febrile illness when assessing the proportion
of malaria cases receiving prompt and effective
treatment.
In order to understand why prompt and effective
treatment of malaria (or fever) remains low it is neces-
sary to examine the treatment pathway, comprising both
treatment-seeking and the delivery process. Critical
blockages in this treatment pathway may be identified
by assessing the probability of a child moving from one
step to the next, from getting a fever to receiving appro-
priate treatment [9]. Once critical blockages in the treat-
ment pathway have been identified it may be possible to
design new, or re-focus current interventions to move
more rapidly towards the RBM target. If effective treat-
ment of malaria is to be improved for children across
socioeconomic groups, all sectors involved in the deliv-
ery of anti-malarials must be considered in this ‘diagnos-
tic’ manner. Such an approach will enable the targeting
of interventions to increase effective treatment at all
sources that the caretakers of children are utilizing [10].
This paper presents the application of such a diagnos-
tic approach to the coverage of prompt and effective
treatment for febrile children in rural Senegal, assessing
the critical steps at which children exit from the treat-
ment pathway, stratified according to source of first
advice or treatment.
Methods
Study area and background
Tambacounda is the largest region in Senegal, located in
the south-east of the country and bordered by The Gam-
bia, Guinea and Mali. The rainy season is from June to
October and the majority of malaria transmission occurs
between July and November [11]. Despite recent trends
showing a decrease in the proportion of morbidity and
mortality due to malaria in Senegal, there is still substan-
tial regional variation. In the Tambacounda region
malaria accounts for 13.5% of all outpatient consultations
and 22.4% of mortality [12] and Tambacounda has the
highest parasite prevalence in children under five of
23.4% compared to the national figure of 5.7% [13].
The population of Tambacounda is widely dispersed
and access to health care is often limited. The health
system in Senegal is structured to have community out-
reach services at the village level through health huts
(cases de santé), community health workers (agent de
santé communautaire, ASC) and community health
volunteers (relais communautaire, RC). However, in cer-
tain parts of the country these community level services
are no longer functional. The international non-govern-
mental organization IntraHealth is working to rehabili-
tate 24 health huts across Tambacounda, Koumpentoum
and Maka Coulibantang districts. This rehabilitation was
undertaken as part of an intervention to improve prompt
and effective treatment of fever in children under five
years with the national first-line anti-malarial, the ACT
artesunate-amodiaquine (AS-AQ). The overall goals of
the intervention are in alignment with the National
Malaria Control Programme (Programme National de
Lutte contre le Paludisme, PNLP) strategic plan to ensure
correct treatment of 80% of malaria cases at all levels of
the health system [14]. Each health hut serves its own vil-
lage and four additional ‘polarised villages’ (villages
polarisés). Prior to the final design and implementation
of the intervention, a household survey of treatment
practices for children under five years with fever was
conducted between August 22nd and September 2nd
2008.
Household survey design & implementation
The household survey followed a two-stage cluster sam-
ple design. The sampling frame for the survey covers all
110 villages that are served by the 24 intervention health
huts in the districts of Tambacounda, Koumpentoum
and Maka Coulibantang, which have an approximate
total population of 37,770. Each village represented a
cluster and clusters were sampled proportional to popu-
lation size.
To estimate the proportion of children under five
years with fever in the last two weeks who received
anti-malarial drugs within 24 hours with 6% precision
and assuming a design effect of 2, a non-response rate
of 10%, and the percentage of children under 5 years in
the population as 17.5%, a sample size of 240 was
required [15]. To achieve this sample size, 40 clusters of
6 children under five years with fever in the last two
weeks were sampled.
Households were selected within each cluster using an
adapted form of the expanded programme of immunisa-
tion (EPI) cluster survey method [16]. A household was
defined as all those eating from the same cooking pot
[13]. Since the aim of this survey was to investigate the
treatment practices for children under five years with
fever, sampling of households was restricted to those
with a child under five who had had fever in the past
two weeks; no additional symptoms were specified in
the inclusion criteria. Two selection questions were
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asked at each household: (i) Is there a woman present in
this household with at least one child less than five
years of age? (ii) Has this child (these children) had
fever at any time in the last two weeks? Interviews were
only continued with the child’s caretaker where the
answers to both of the selection questions were positive.
The survey tool included structured questions on
respondent and household characteristics, details of the
treatment process for children under five with fever
(including source and timing of treatment, reported
dose and duration of anti-malarials), and malaria-related
knowledge.
Data analysis
Data were double-entered and validated in EpiData ver-
sion 3.1 [17]. Stata 10.0 [18] was used for data proces-
sing and analysis. All analyses accounted for the design
of the survey, adjusting for clusters. The survey design
was self-weighting.
The treatment pathway was divided into five key steps
and the proportion of children reaching each step calcu-
lated. The total number of febrile children was used as
the denominator for all steps: (i) child had fever in the
previous two weeks (denominator); (ii) child was taken
for treatment or advice; (iii) care was sought within 48
hours; (iv) child received an anti-malarial; (v) child
received an ACT. Prompt treatment is considered to be
within 48 hours, defined as the day that the fever starts
or the next day; the reason being that it is difficult to be
sure on the precise number of hours and it is likely that
‘the next day’ will be more than 24 hours. The source of
first advice or treatment was categorized to: commu-
nity-based delivery point (defined as a health hut, ASC
or RC); public health facility (defined as a health post or
health centre; none of the caretakers reported first seek-
ing care at a public hospital); or retail delivery point.
Traditional healers and friends/relatives were excluded
from this categorization since we were interested in places
where allopathic anti-malarial drugs could be given. Steps
ii-v were calculated for treatment from any source, and
from community, public and retail sector sources.
Principal components analysis (PCA) was used to
assign each household a wealth index score based on
household characteristics and ownership of assets [19].
The wealth index score was then used to classify house-
holds into three socioeconomic groups (tertiles). The
variables included in the PCA were type of roof mate-
rial, type of floor material, and household ownership of
the following assets: solar panel, radio, television, tele-
phone, mobile, fridge, bed, kettle, bucket, battery, sleep-
ing mat, plough, horse, cow, goat, donkey, bicycle,
motorbike, car, oxcart, horse and cart, donkey and cart.
The proportion of variation explained by the first princi-
ple component was 17.7%.
Univariable analyses of potential predictors of seeking
any advice or treatment for a febrile child, and the
source of first advice or treatment were explored using
a logistic regression model; adjusted Wald tests were
used to assess the contribution of each factor to the
model. Potential predictors with a p-value of less than
0.1 were included in multivariable models for each of
the outcome measures to ascertain which predictors
remained associated with the outcome when adjusted
for other factors.
Modelling the impact of rapid diagnostic tests (RDTs)
The survey was designed to assess access to prompt effec-
tive treatment and therefore used the Roll Back Malaria
(RBM) access indicator as an outcome measure [20]. The
Senegalese PNLP strategic plan states that all childhood
fevers should be treated with AS-AQ within 24/48 hours
of onset. However, at the time of the survey, community-
based diagnosis of malaria was based on symptoms alone
(i.e. presumptive), whereas the policy stated that in public
sector health facilities confirmatory diagnostic tests should
be employed [14]. The RBM access indicator does not
address the use of diagnostics in the treatment process
and therefore no questions relating to diagnostics were
included in the survey. As such, it was not possible to
include empirical data on confirmed diagnosis in the algo-
rithm for assessing appropriate treatment. To overcome
this limitation we used routine data to model the impact
of including RDT diagnosis in the treatment pathway
assessments for the public sector.
For those seeking treatment from a public sector pro-
vider two additional steps were inserted into the treat-
ment pathway. These steps were: the proportion
receiving diagnosis with an RDT; and amongst those
tested with an RDT, the proportion parasite positive.
According to the most recent data from the PNLP, the
proportion of patients with fever attending a formal
public health facility in the Tambacounda region that
received an RDT in 2008 was 78%; the proportion of
RDTs conducted that were positive for malaria in Tam-
bacounda was 60% [12]. Thus, the denominator used for
assessing appropriate treatment in the public sector
where diagnosis should be RDT-confirmed was the
expected number of children that would have confirmed
malaria. This assumes that the decision not to adminis-
ter an RDT to 22% of children with fever was based on
sound clinical judgement of alternative diagnoses for
these children rather than missed malaria cases.
Ethical approval
Ethical approval for the study was granted by the ethics
committees of the Conseil National de Recherche en
Santé (CNRS), Dakar, Senegal and London School of
Hygiene & Tropical Medicine, London, England.
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Results
Interviews were completed with 240 caretakers of chil-
dren under five years of age with fever in the previous
two weeks. As nearly a quarter of households had more
than one child with a fever in the last two weeks a total
of 305 febrile children were included in the survey sam-
ple. The mean number of febrile children under five
years per household was 1.27 (range: 1 to 5 children).
Since the majority of households with multiple febrile
children under five years had two febrile children,
potential clustering of treatment seeking outcomes was
explored within these pairs of children. No agreement
within child pairs for the outcome of receiving ACT
within 48 hours was observed (correlation coefficient:
0.2344); therefore, the analysis was not adjusted for clus-
tering at the household level. Household size varied
from 3 to 39 people, with a mean of 11.0 ± 5.2. A total
of 2,652 people lived in the households interviewed.
Prompt treatment-seeking across sectors
Overall 61.6% (188) of caretakers sought any advice or
treatment and 40.3% (123) sought any treatment
promptly within 48 hours. Of the 188 children with
fever for whom any advice or treatment was sought, the
greatest number were taken to a health post (41.5%), the
lowest level public health facility; approximately equal
numbers were taken to a health hut or community
volunteer (12.7%) or the retail sector (13.8%); and 9.6%
were taken to a public sector health centre. The remain-
ing children were taken to an ‘other’ source (including
13.8% to a traditional healer, and 4.8% to a friend or
relative or that already had drugs in the house).
The proportion of all children with fever that accessed
the community or retail sectors was low (7.8% and 8.5%,
respectively); however those who did, did so promptly
with 83.3% and 80.8% accessing these delivery points
within 48 hours, respectively. A lower proportion of the
febrile children accessing public sector delivery points
did so promptly (63.2%). However, the difference in pro-
portion promptly accessing the community (p = 0.12) or
retail (p = 0.34) sector versus the proportion promptly
accessing the public sector was not statistically signifi-
cant. It is not unexpected that the community sector is
the least accessed at the time of this survey as this was
before the implementation of the health hut rehabilita-
tion intervention.
Predictors of seeking any advice or treatment
Univariable logistic regression suggests that children of
higher socioeconomic status are more likely to seek
advice or treatment from any source, including tradi-
tional healers and friends or family, with those in the
highest socioeconomic third twice as likely to seek any
advice or treatment than those in the lowest third (low-
est tertile: referent; middle tertile: OR: 1.86; 95%CI: 0.98,
3.56; highest tertile: OR: 2.06; 95%CI: 1.07, 3.98; p =
0.05) (see Table 1). No other predictors were signifi-
cantly associated with seeking treatment from any
source, thus it was not appropriate to construct a multi-
variable model.
Predictors of where initial advice or treatment was
sought
Logistic regression was used to explore the predictors of
seeking first advice or treatment at (i) a community-
based delivery point; (ii) a public health facility; and (iii)
a retail sector delivery point. Traditional healers and
family or friends were excluded from this categorisation
(n = 42). The factors influencing treatment-seeking
from the different categories of providers varied. For
example, the univariable analyses (Table 2) suggested
that the child’s age and socioeconomic status were uni-
variable predictors of first seeking care in the formal
public health sector. The child’s age and sex, and the
number of wives of the head of household were predic-
tors of first seeking care from a community-based
source. Child’s age and household size were univariable
predictors of first seeking care for a child under five
with fever from a retail outlet.
Not all variables remained associated when included
in multivariable models (Table 3). For the public sector,
child’s age and socioeconomic status of the household
remained predictors in the adjusted model. Older chil-
dren (< 1 year olds: referent; 1-4 year olds: OR: 0.53;
95%CI: 0.28, 1.00; p = 0.05) and those of lower socioe-
conomic status (lowest tertile: referent; middle tertile:
OR: 1.13; 95%CI: 0.64, 1.99; highest tertile: OR: 2.14;
95%CI: 1.17, 3.91; p = 0.04) were less likely to seek care
from a public sector health facility when they have
fever. The adjusted likelihood of a child with fever being
taken to a community-based delivery point for first
advice or treatment was greater for female children (OR:
3.53; 95%CI: 1.47, 8.45; p = 0.006). The adjusted likeli-
hood of a febrile child seeking first treatment from a
retail outlet increased with household size (<10 mem-
bers: referent; 10-14 members: OR: 4.38; 95%CI: 1.17,
16.4; 15 or more members: OR: 4.69; 95%CI: 1.03, 21.3;
p = 0.07)
Treatment received according to place first advice or
treatment sought
A greater proportion of children with fever in the pre-
vious two weeks received an anti-malarial, if they first
sought treatment from a community-based delivery
point (62.5%; n = 15). This was more than twice the
proportion of those who received an anti-malarial if
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they first visited a public sector health post or health
centre (29.5% and 23.5%, respectively) (Table 4). Uni-
variable logistic regression supports this finding with
children first taken to a community-based service being
approximately four times more likely to receive an anti-
malarial than those first taken to a public health facility
(public sector health facility: referent; community-based
delivery point: OR: 4.20; 95%CI: 1.49, 11.80; retail sector:
OR: 0.46; 95%CI: 0.11, 1.88; p = 0.01).
No antibiotics were given to children first seeking care
from a health hut, which supports practice of the cur-
rent national policy that antibiotics cannot be prescribed
at the community level unless the community health
workers are appropriately trained and supervised. The
proportion of children seeking care in the public sector
and receiving an antibiotic is higher (15.4% and 35.3%
of those first seeking care at a health post or health cen-
tre, respectively).
Most of the ‘other’ treatments (i.e. neither an anti-
malarial nor an antibiotic) given to febrile children were
paracetamol, regardless of the source of first treatment/
advice (community-level: 7/9; formal public health facil-
ity: 30/45; retail sector: 19/21). Approximately half of
children (46/94) receiving an anti-malarial or antibiotic
also received paracetamol. Overall, 1.6% (5) children
received both an anti-malarial and an antibiotic. Nine
percent of the children taken to a health post as the
first source of treatment or advice did not ultimately
receive any treatment; this compares with 40% of those
initially taken to a traditional healer. All children who
were first taken to a health hut or health centre received
some kind of treatment.
The proportion of febrile children taking an ACT
within 48 hours was 6.2% (19) from any source, 3.0% (9)
from a formal public provider, 3.0% (9) from a commu-
nity source and 0.3% (1) from the retail sector. Only
1.6% (5) also took the correct dose, and 1.3% (4) for the
correct duration forming the complete indicator for
prompt and effective treatment, all of whom were chil-
dren first taken to a community provider.
Treatment process analysis
By categorising the treatment process into key steps it is
possible to visualise the proportion of children progres-
sing through each step and to investigate at which step
the greatest number of children exit the process
required to receive effective treatment. This analysis can
be further stratified by the sector or treatment delivery
point of first seeking treatment (Figure 1). Overall, the
greatest proportional loss occurs after treatment has
been sought from any source; over 70% of children seek-
ing treatment do not go on to receive an anti-malarial.
Amongst those children that are given an anti-malarial
just over half (55.9%) receive an ACT.
Simple modelling of changes at various steps in the
treatment process, based on the empirical data shown in
Figure 1, suggests that increasing the proportion of chil-
dren seeking care at community based treatment deliv-
ery points (health huts) would be a relatively effective
way of increasing the proportion of febrile children
receiving effective treatment. Increasing the proportion
of children seeking treatment from a community deliv-
ery point (7.8%) to the level of current treatment-seek-
ing from the formal public sector (31.5%) increases the
proportion ultimately receiving treatment with an ACT
from 2.9% to 11.8% (Table 5). Increasing the proportion
of febrile children seeking treatment from a community
delivery point to the current percentage seeking
Table 1 Univariable logistic regression of the odds for
seeking any advice or treatment for a child under five
years with fever from any source
Variable N % OR 95% CI P
value
Child’s age 0.9
< 1 year 74 62.0 1.00
1-4 years 234 61.5 0.98 0.56, 1.73
Child’s gender 0.2
Male 154 58.4 1.00
Female 151 64.9 1.31 0.83, 2.08
Mother’s education 0.1
None 183 57.4 1.00
Any 122 68.0 1.58 0.91, 2.75
Mother’s age 0.3
< 20 years 56 71.4 1.00
20-29 years 120 64.2 0.72 0.31, 1.66
30-39 years 93 60.2 0.61 0.26, 1.39
> 40 years 36 41.7 0.29 0.08, 1.01
No. wives in HH 0.1
One or less 208 64.9 1.00
Two or more 97 54.6 0.65 0.36, 1.17
Household size 0.9
< 10 members 112 61.6 1.00
10-14 members 129 62.8 1.05 0.54, 2.05
15 or more members 64 59.4 0.91 0.45, 1.86
No. U5s with fever in HH 1.0
One 183 61.7 1.00
Two or more 122 61.5 0.99 0.51, 1.91
Socioeconomic status* 0.05
Lowest tertile 98 50.0 1.00
Middle tertile 106 65.1 1.86 0.98, 3.56
Highest tertile 95 67.4 2.06 1.07, 3.98
Seen malaria information in last
year
0.7
No 127 63.0 1.00
Yes 178 60.7 0.91 0.56, 1.47
* 6 missing values for socioeconomic status
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Table 2 Univariable logistic regression models of the odds for seeking any advice or treatment for a child under five
years with fever from the public sector, community sector or retail sector
First seek treatment in public
sector
First seek treatment in
community sector
First seek treatment in retail
sector
Variable N % OR 95% CI P value % OR 95% CI P value % OR 95% CI P value
Child’s age 0.05 0.09 0.06
< 1 year 74 42.3 1.00 2.8 1.00 1.4 1.00
1-4 years 234 28.2 0.54 0.29, 1.00 9.4 3.58 0.81, 15.9 10.7 8.37 0.92, 76.6
Child’s gender 0.2 0.008 0.2
Male 154 27.9 1.00 3.9 1.00 11.0 1.00
Female 151 35.1 1.40 0.83, 2.34 11.9 3.34 1.40, 7.97 6.0 0.51 0.16, 1.61
Mother’s education 0.6 0.4 0.1
None 183 32.8 1.00 6.6 1.00 6.0 1.00
Any 122 29.5 0.86 0.45, 1.63 9.8 1.55 0.56, 4.33 12.3 2.19 0.79, 6.06
Mother’s age 0.1 0.6 1.0
< 20 years 56 26.8 1.00 10.7 1.00 10.7 1.00
20-29 years 120 38.3 1.70 0.74, 3.90 5.8 0.52 0.17, 1.56 8.3 0.76 0.11, 5.40
30-39 years 93 31.2 1.24 0.47, 3.23 8.6 0.78 0.28, 2.21 7.5 0.68 0.10, 4.42
> 40 years 36 16.7 0.55 0.11, 2.81 8.3 0.76 0.11, 5.14 8.3 0.76 0.11, 5.21
No. wives in HH 0.6 0.05 0.4
One or less 208 30.3 1.00 9.1 1.00 9.6 1.00
Two or more 97 34.0 1.19 0.65, 2.17 5.2 0.54 0.29, 1.00 6.2 0.62 0.21, 1.86
Household size 0.4 0.1 0.05
< 10 112 36.6 1.00 12.5 1.00 2.7 1.00
10-14 129 31.0 0.78 0.38, 1.61 7.0 0.53 0.23, 1.22 11.6 4.78 1.29, 17.7
≥ 15 64 23.4 0.53 0.21, 1.31 1.6 0.11 0.01, 0.96 12.5 5.19 1.14, 23.6
No. U5s with fever in HH 0.6 0.2 0.2
One 183 32.8 1.00 9.8 1.00 6.6 1.00
Two or more 122 29.5 0.86 0.47, 1.56 4.9 0.47 0.16, 1.38 11.5 1.85 0.65, 5.24
Socioeconomic status* 0.05 0.6 1.0
Lowest 98 25.5 1.00 7.1 1.00 7.1 1.00
Middle 106 28.3 1.15 0.65, 2.04 6.6 0.92 0.23, 3.68 6.6 0.92 0.33, 2.55
Highest 95 42.1 2.12 1.15, 3.90 10.5 1.53 0.42, 5.45 7.4 1.03 0.30, 3.57
Seen malaria information in last year 0.6 0.1 0.3
No 127 33.1 1.00 4.7 1.00 11.0 1.00
Yes 178 30.3 0.88 0.51, 1.54 10.1 2.27 0.84, 6.13 6.7 0.58 0.20, 1.68
* 6 missing values for socioeconomic status
Table 3 Multivariable logistic regression models of the odds for seeking any advice or treatment for a child under five
years with fever from the public sector, community sector or retail sector (Note: multivariable regression not
conducted for “any source” as only one variable met the inclusion criteria of a p-value < 0.1)
First seek treatment in public sector First seek treatment in community sector First seek treatment in retail sector
Variable OR 95% CI P value Variable OR 95% CI P value Variable OR 95% CI P value
Child’s age 0.05 Child’s age 0.07 Child’s age 0.08
< 1 year 1.00 < 1 year 1.00 < 1 year 1.00
1-4 years 0.53 0.28, 1.00 1-4 year 3.53 0.90, 17.7 1-4 years 7.42 0.79, 69.6
Socioeconomic status* 0.04 Gender 0.006 Household size 0.07
Male 1.00
Lowest 1.00 Female 3.53 1.47,8.45 < 10 1.00
Middle 1.13 0.64, 1.99 10-14 4.38 1.17, 16.4
Highest 2.14 1.17, 3.91 ≥ 15 4.69 1.03, 21.3
No. wives 0.08
≤ 1 1.00
≥ 2 0.56 0.29, 1.07
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treatment from any provider (61.6%) increases treatment
with an ACT to 23.1%.
However, the improvements seen in the outcome of
receiving prompt effective treatment with an ACT
remain modest if increasing the proportion of children
successfully completing the process focuses on just one
step in the pathway. Indeed, even when every step in
the process was increased by 20%, the overall proportion
of febrile children who received an ACT from any
source was still only 25.2% (see Additional file 1 for full
results of this modelling process).
Modelling the inclusion of RDT-confirmed diagnosis
Based on the PNLP data for 2008, we assume that 78%
of febrile children taken to a formal public sector health
provider were tested with an RDT, and 60% of these
were positive for malaria parasites. Applying these data
to the survey findings and assuming that the 22% that
do not receive an RDT have strong alternative clinical
diagnoses, the proportion of children appropriately
receiving an anti-malarial promptly from the public sec-
tor would rise from 16.7% (16/96) to 35.6% (16/45) and
the proportion appropriately receiving an ACT from the
Table 4 Treatment given to children under five years
with fever, according to place where first advice/
treatment sought
Place where
advice/treatment
FIRST sought
Treatment given
Any anti-
malarial
(AM)
AS-AQ Antibiotic
(AB)
Other
(not an AM or
AB)
% n % n % n % n
Health hut/ASC/RC 62.5 15 45.8 11 0 0 37.5 9
Health post 29.5 23 19.2 15 15.4 12 48.7 38
Health centre 23.5 4 5.9 1 35.3 6 41.2 7
Retail sector 15.4 4 3.8 1 7.7 2 80.8 21
Figure 1 Treatment with an anti-malarial by source of first advice or treatment. Figures within boxes are proportions of all febrile children;
percentages between boxes indicate the proportion of children that exit at each step in the pathway. ‘Any source’ indicates the total for each
step, not stratified by provider.
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public sector would rise from 9.4% (9/96) to 20.0% (9/
45) when RDT confirmation was included. Because the
role of diagnosis in the definition of “effective” treat-
ment is different across sectors, it is not possible to con-
struct an overall indicator for prompt and effective
treatment of the original cohort of 305 febrile children
if public sector RDTs are included since the denomina-
tor for the public sector then becomes different to that
for the community and retail sectors.
Discussion
It is clear that large proportions of children exit from
each step in the treatment pathway, and that a variety of
interventions will be required to increase the proportion
of febrile children with malaria receiving prompt and
effective treatment with an ACT in the study area.
Almost 40% of children with fever are not taken for any
advice or treatment. This may be because the fever was
only of short duration and the child quickly recovered,
for example due to self-medication with drugs already
in the home and/or other first aid measures such as
tepid sponging. Nevertheless, the result still highlights
the importance of health promotion to improve aware-
ness of malaria symptoms and the importance of seek-
ing prompt treatment if initial home measures such as
tepid sponging do not work. The proportion of children
not seeking any treatment seems high in relation to
other studies [21,22]; however it is similar to findings
from Uganda [23], which also reported approximately
40% of children not seeking any care for fever. More
investigation is clearly needed to understand initial
treatment practices in the home, the reasons for not
seeking treatment outside the home, and to follow up
on health outcomes including estimation of the propor-
tion of fevers that are self-limiting.
Perhaps the starkest finding from this process analysis
of the treatment pathway was that over 70% of febrile
children taken to any provider did not receive an anti-
malarial. Given the national policy for confirmed diag-
nosis in formal public health facilities, it is not unex-
pected that a lower proportion of febrile children
received an anti-malarial when taken to a public health
facility rather than a community delivery point. How-
ever, assuming that 47% of fevers are malaria (78% feb-
rile children receive an RDT and of these 60% are
positive), one would expect 47% of febrile children to
receive an ACT in the public sector whilst our findings
show that only 26.7% of those promptly seeking treat-
ment in the public sector received any anti-malarial and
15.0% an ACT. The proportion of those promptly seek-
ing treatment for a febrile child at any provider and not
being given an appropriate anti-malarial (i.e. AS-AQ) is
84.6%. The not uncommon occurrence of children
being given anti-malarials other than ACT (including
chloroquine) in the public sector is an indication that
improvements are still necessary. The results of the pre-
sent study support those of the 2008 Senegal Malaria
Indicator Survey, which found that only 2.2% of chil-
dren in the Tambacounda region with fever in the pre-
vious two weeks received an ACT on the same or next
day [24].
Effective treatment of malaria does not stop at pre-
scription of an ACT to patients with a confirmed diag-
nosis; the caretaker of the child also needs to access the
prescribed medication and fully adhere to the complete
treatment regimen making sure that the child takes the
correct dose and for the correct number of days. In
addition to including an indication of promptness of
treatment-seeking (within 48 hours of the child first
showing signs of fever), these elements make up the full
RBM indicator of prompt and effective treatment of
malaria [1]. In this study, only 1.3% of children with
fever received an ACT within 48 hours of presenting
with fever, which was reportedly taken at the correct
dose and for the correct duration.
The exiting of children from steps in the treatment
pathway seen in this study is very similar to findings
from Uganda; Nsungwa-Sabiiti et al found that in a
population of 260 children with fever, 87% received any
treatment, 44% within 24 hours, 26% with an appropri-
ate anti-malarial and only 7% at correct dose and dura-
tion [25]. This emphasizes the need to target both users
Table 5 Model to show how varying the proportion of febrile children passing through each step in the treatment
pathway for those seeking care from a community delivery point influences the ultimate proportion that receive an
ACT (unadjusted for RDT use)
Actual data Same proportion accessing as currently
go to public sector
Same proportion accessing as currently
go to any provider
Community delivery point N % Cum.% N % Cum.% N % Cum.%
1. U5s with fever in last 2 weeks 305 100 100 305 100 100 305 100 100
2. Sought any advice or treatment 24 7.8 7.8 96 31.5 31.5 188 61.6 61.6
3. Within 48 hours 20 83.3 6.5 80 83.3 26.2 157 83.3 51.3
4. Received an AM 11 55.0 3.6 44 55.0 14.4 86 55.0 28.2
5. Received an ACT 9 81.8 2.9 36 81.8 11.8 70 81.8 23.1
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and providers if improvements in the prompt and effec-
tive treatment of malaria in children are to be achieved.
Qualitative work is now needed to understand the rea-
sons for the observed losses at each step in the treat-
ment pathway in order to design appropriate
interventions.
Studies investigating how the use of RDTs in routine
health services influence clinical decisions have shown
mixed results. For example, research in Tanzania and
Burkina Faso found that many health providers continue
to prescribe anti-malarials to patients with a negative
RDT result [26,27], whereas this practice was much less
frequent in studies in Kenya and Zanzibar [28,29]. Mod-
elling of the impact of RDT-confirmed diagnosis did not
incorporate interpretation of the result into the treatment
received by the febrile child, meaning that some of those
given an anti-malarial may have been negative and some
of those not given an anti-malarial may have been posi-
tive which would have influenced the proportion of feb-
rile children being appropriately treated. RDTs are likely
to be less cost effective if the results are not used prop-
erly, particularly in areas with falling malaria transmis-
sion such as Senegal [12] and where treatment is with
more expensive ACTs [30,31]. A key intervention in
addition to increasing the use of RDTs in the public sec-
tor is, therefore, to encourage appropriate treatment of
positive results with an anti-malarial (more importantly,
an ACT) and negative results with a suitable alternative
treatment, for example an antibiotic or antipyretic.
Interestingly, the proportion of febrile children taken
to a health centre that were given an antibiotic supports
that differential diagnosis based on a confirmed RDT
may have been appropriately implemented since almost
40% of children received an antibiotic (approximately
the proportion that would have been expected to receive
a negative RDT). Overall, 1.6% of children received both
an anti-malarial and an antibiotic. However, at the
health post level only 15% of febrile children received an
antibiotic. It is possible that the prescription of ACT
was low in the public sector due to problems with
stock-outs, known to have adverse effects on appropriate
treatment of malaria in other countries after changing
their national malaria drug policy [32]. Alternatively, it
may have been because of health worker reluctance to
prescribe AS-AQ due to perceived or observed side
effects of amodiaquine which have previously been
found in Senegal [33]. Household surveys are currently
the standard method used to assess the RBM malaria
treatment indicator; however, to truly understand the
provider-side factors such as stock and quality of care
that influence the ultimate treatment received and
adhered to by children with malaria, it is necessary to
also conduct concurrent health facility and health
worker surveys.
In addition to the existing use of RDTs in public
health facilities, they are also presently being rolled out
for use in the diagnosis and treatment of malaria at the
community level in Senegal. Community health workers
(ASCs) will be supplied with RDTs and trained in their
use. Use of RDTs by community volunteers has been
shown to be feasible in other settings [7,8]; however,
concerns with appropriate use of the tests and correct
interpretation of results mean that close monitoring of
the new system will be important. Similarly, the inclu-
sion of a confirmed malaria diagnosis as a specific step
in the treatment pathway, regardless of source of treat-
ment, will be important in assessing effective treatment
of febrile children in the intervention area in future
surveys.
Another interesting, if not surprising, finding of this
study is that there is minimal activity in the retail sector
in relation to ACT; although 8.5% of febrile children
were taken to a retail outlet, only 3.8% of these received
an ACT.
The predictors for a child with fever seeking treatment
vary depending on the type of provider that they are
initially taken to. For example, access to the public sec-
tor increases with higher socioeconomic status. How-
ever, socioeconomic status is not a predictor of
accessing community-based delivery points. This sup-
ports data from other studies that suggest providing
ACT through community-based systems such as health
huts may be an appropriate way to increase equity of
access to effective malaria treatment [34]. However,
there is still debate as to whether community health
workers are able to increase socioeconomic equity in
the coverage of interventions as effectively as they
improve geographic equity, especially as some level of
payment is usually involved [35,36]. Finding that carers
of febrile children were seeking treatment from the
community sector in areas with non-functional health
huts may have been due to a small number of health
huts being rehabilitated and receiving their ACT sup-
plies whilst the survey was underway, or to people tra-
velling large distances to access functioning health huts.
The sample size is a limitation of this survey, resulting
in wide 95% confidence intervals. This is due to the
decreasing numbers of children progressing to each step
of the treatment pathway, particularly when they are
stratified by provider and categorized determinant.
Future studies wishing to assess the different steps in
the treatment pathway, particularly when including stra-
tification by type of provider, should allow a sufficiently
large sample size to account for the decreasing numbers
of children remaining in the evaluable sample as the
pathway progresses.
It is important to note that there may be some inac-
curacies in the names and types of drugs that the
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caretakers reported giving to their children [37], particu-
larly due to problems with recall of an event that
occurred up to two weeks ago. Although we tried to
limit this source of bias by providing the interviewers
with a photo board for anti-malarials available in the
region, non anti-malarials were not included. It is diffi-
cult to predict however, whether this would mean anti-
malarials or non anti-malarials would have a greater
chance of being reported by caretakers.
Despite the sample size and other limitations, it is
clear that large proportions of children exit from each
step in the treatment pathway, and that intervention is
required at multiple steps to increase the proportion of
febrile children with malaria receiving prompt and effec-
tive treatment in the study area.
Conclusion
Progress towards achieving the RBM goal of 80% of
malaria patients being diagnosed and treated with effective
anti-malarial medicines (ACT) within one day of the onset
of illness is slow. In order to understand the reasons for
this and to generate improvements, it is necessary to iden-
tify the steps within the treatment pathway where the
greatest proportion of children exit from the process of
receiving effective treatment. This will enable the identifi-
cation of the steps where interventions can or should be
targeted to achieve the greatest impact. Limited impact
will be achieved if interventions only target one step in the
pathway. In the Tambacounda region of Senegal, the most
important targets for interventions are increasing initial
care seeking for fever, improving uptake of RDTs at the
public and community levels and correctly treating para-
site positive patients with an ACT. There is also a need for
complementary qualitative work to investigate in more
detail why these processes are not occurring effectively so
that the most appropriate interventions can be designed. It
is important that this diagnosis of the treatment pathway
is further broken down by provider type since the public,
community-based and retail sectors behave differently but
are all important if the RBM targets for prompt and effec-
tive treatment of malaria are to be achieved.
Additional material
Additional file 1: Model to show how varying the proportion of
febrile children passing through each step in the treatment
pathway (from any provider) influences the ultimate proportion
that receives an ACT (unadjusted for RDT use).
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